Format

Send to

Choose Destination
Am J Physiol Cell Physiol. 2015 Oct 15;309(8):C511-21. doi: 10.1152/ajpcell.00117.2015. Epub 2015 Aug 19.

Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms.

Author information

1
The Francis Crick Institute, Mill Hill Laboratory, London, United Kingdom.
2
The Francis Crick Institute, Mill Hill Laboratory, London, United Kingdom Vivian.Li@crick.ac.uk.

Abstract

The evolutionarily conserved Wnt signaling pathway plays essential roles during embryonic development and tissue homeostasis. Notably, comprehensive genetic studies in Drosophila and mice in the past decades have demonstrated the crucial role of Wnt signaling in intestinal stem cell maintenance by regulating proliferation, differentiation, and cell-fate decisions. Wnt signaling has also been implicated in a variety of cancers and other diseases. Loss of the Wnt pathway negative regulator adenomatous polyposis coli (APC) is the hallmark of human colorectal cancers (CRC). Recent advances in high-throughput sequencing further reveal many novel recurrent Wnt pathway mutations in addition to the well-characterized APC and β-catenin mutations in CRC. Despite attractive strategies to develop drugs for Wnt signaling, major hurdles in therapeutic intervention of the pathway persist. Here we discuss the Wnt-activating mechanisms in CRC and review the current advances and challenges in drug discovery.

KEYWORDS:

Wnt signaling pathway; adenomatous polyposis coli; colorectal cancer; drug targeting; small molecules; β-catenin

PMID:
26289750
PMCID:
PMC4609654
DOI:
10.1152/ajpcell.00117.2015
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center